Roche Diabetes Care is partnering with Duke University in Durham, North Carolina (US) to establish a testbed for innovative products, services, and solutions for people with Type 2 diabetes. The university’s specialists will design, set up, and curate a testing ground to enable the collection of feedback from people with Type 2 diabetes and clinical stakeholders. Socioeconomic and clinical demographic information of the cohort established on the test-bed will provide foundational steps that enable real-world feedback. It will help build the evidence needed for diabetes digital health solutions.
Jim Lefevere, International Business Leader for Non-Insulin Therapy Solutions at Roche Diabetes Care explains, “Over the next three years, the partnering will support our strategy to generate real-world evidence and bring more innovative solutions to the market for people with Type 2 diabetes. Establishing a test-bed with a well-known partner is a key next step in evaluating novel approaches and determining if users will adopt an innovative product. It will not only speed up evidence generation of how different personalised solutions for patients can drive better outcomes but will also support innovation and piloting with external start-ups and digital health companies.”
